4.1 Article

Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.mrgentox.2009.05.003

关键词

K-ras mutations; Aberrant crypt foci; Selenium

资金

  1. NHMRC of Australia
  2. Cancer Council of South Australia

向作者/读者索取更多资源

Azoxymethane, a rodent colon-specific carcinogen, induce DNA damage, and causes proto-oncogene K-ras point mutations and subsequent tumor formation if DNA damage is not repaired or removed. The present study was designed to detect and characterize K-ras mutations in azoxymethane (AOM)-induced aberrant crypt foci (ACF) in mice, and determine whether dietary Supplementation of selenium influences K-ras mutations frequency in ACF using a new PCR technique of locked nucleic acid-mediated real-time PCR clamping combined with mutant-specific probes. K-ras mutations were identified in 33% of AOM-induced ACF. In addition to G to A transition mutation, specific G to T transversion mutation Was also identified for the first time in mouse ACF. Furthermore, selenium intake was associated with reduced ACF formation and reduced K-ras mutations rate, respectively, from 112 and 37% in mice fed control diet to 65 and 14% in mice fed selenium-containing diet (p < 0.05). This is the first report of the use of one-step LNA-mediated real-time PCR clamping to detect K-ras mutations in AOM-induced colon cancer model. It is highly sensitive and can be applied to the detection of early genetic alterations in carcinogen-based animal models. Crown Copyright (C) 2009 published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Meeting Abstract Oncology

Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a potential diagnostic and prognostic biomarker in esophagogastic cancers

Mei Mei Chan, Jean M. Winter, Susanne Kartin Pedersen, Amitesh Chandra Roy, David I. Watson, Damian Hussey, Graeme P. Young, Erin L. Symonds

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Detection of circulating DNA methylated BCAT1 and IKZF1 in pancreatic adenocarcinoma

Jean M. Winter, Lorraine Sheehan-Hennessy, Susanne Kartin Pedersen, Graeme P. Young, Erin L. Symonds

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1

Erin L. Symonds, Susanne K. Pedersen, Bernita Yeo, Hiba Al Naji, Susan E. Byrne, Amitesh Roy, Graeme P. Young

Summary: This study assessed the use of BCAT1 and IKZF1 methylation levels to quantify circulating tumor DNA (ctDNA) in colorectal cancer patients. The results showed that ctDNA levels were correlated with disease progression, tumor diameter, and volume. After treatment, ctDNA levels decreased and the presence of ctDNA was associated with disease progression.

MOLECULAR ONCOLOGY (2022)

Article Oncology

Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1

Susanne K. Pedersen, Benjamin L. Musher, Lawrence C. LaPointe, Melissa K. Tuck, Erin L. Symonds, Naima Loayza, Graeme P. Young

Summary: Establishing an upper reference limit for the methylated BCAT1 and IKZF1 blood assay improved specificity for detecting CRC recurrence without compromising sensitivity. The BCAT1/IKZF1 test was more sensitive than CEA for identifying recurrences amenable to surgery with curative intent.

CANCER (2022)

Article Oncology

Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients

Jean M. Winter, Lorraine Sheehan-Hennessy, Beibei Yao, Susanne K. Pedersen, Molla M. Wassie, Michael Eaton, Michael Chong, Graeme P. Young, Erin L. Symonds

Summary: Detection of circulating DNA methylated in BCAT1 and IKZF1 is sensitive and specific for colorectal cancer, but not effective for breast or prostate cancer.

CANCER BIOMARKERS (2022)

Review Oncology

Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review

Natalie Lim, Martha Hickey, Graeme P. Young, Finlay A. Macrae, Christabel Kelly

Summary: There is limited evidence to support screening for endometrial and ovarian cancer in Lynch syndrome. Data on mortality reduction are not available. Further randomized trials comparing targeted screening methods are needed. Risk reducing surgery remains the most reliable way to reduce endometrial and ovarian cancer risk in Lynch syndrome.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Article Gastroenterology & Hepatology

Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia

Molla M. Wassie, Graeme P. Young, Charles Cock, Peter Bampton, Jean M. Winter, Kalindra Simpson, Hariti Saluja, Anthony Chuang, Robert J. Fraser, Erin L. Symonds

Summary: Delayed surveillance colonoscopy may increase the risk of advanced neoplasia, particularly in individuals with prior advanced adenoma diagnosis, older age, and nonparticipation in interval FIT testing. However, colonoscopy delay does not seem to increase the risk in individuals with negative interval FIT results.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Oncology

Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence

Susanne K. Pedersen, Erin L. Symonds, Amitesh C. Roy, Kathryn J. Cornthwaite, Lawrence C. LaPointe, Graeme P. Young

Summary: This study found that detection of methylated BCAT1 and IKZF1 after curative-intent treatment for colorectal cancer is significantly associated with an increased risk of recurrence and poorer recurrence-free survival. Patients with detectable methylated BCAT1 and IKZF1 may require personalized surveillance for better management.

CANCER MEDICINE (2023)

Article Gastroenterology & Hepatology

Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program

Molla M. Wassie, Graeme P. Young, Jean M. Winter, Charles Cock, Peter Bampton, Mahadya Rahman, Richard Heddle, Robert Fraser, Rosie Meng, Erin L. Symonds

Summary: Multiple rounds of negative FIT are associated with a reduced risk of advanced neoplasia in above-average-risk individuals undergoing surveillance colonoscopy.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Medical Laboratory Technology

Hot Mail: Temperature Exposure during Mail Return of an Immunochemical Fecal Occult Blood Test

Geraldine Laven-Law, Dawn Bastin, Robert J. L. Fraser, Charles Cock, Graeme P. Young, Jean M. Winter, Erin L. Symonds

Summary: This study aimed to determine the impact of high temperature on OC-Sensor FIT hemoglobin concentration and found that incubation at temperatures of 30 to 35 degrees Celsius reduced FIT hemoglobin concentration after more than 4 days. During mail transit, the maximum FIT temperature was on average 6.4 degrees Celsius above the maximum ambient temperature, but exposure to temperatures above 30 degrees Celsius was less than 24 hours. Data from a screening program showed no association between FIT hemoglobin concentration and maximum ambient temperatures.

CLINICAL CHEMISTRY (2023)

Article Oncology

Health utility assessments in individuals undergoing diagnostic and surveillance colonoscopy: improved discrimination with a cancer-specific scale

Norma B. Bulamu, Gang Chen, Ellen Mcgrane, Charles Cock, Graeme P. Young, Erin L. Symonds

Summary: This study compares the sensitivity and discriminant validity of generic and cancer-specific measures for assessing health-related quality of life (HRQoL) for individuals undergoing diagnostic or surveillance colonoscopy for colorectal cancer. The results show that patients undergoing colonoscopy for symptoms have lower HRQoL compared to surveillance or positive FOBT. The cancer-specific QLU-C10D was found to be more sensitive and capable of distinguishing between patients undergoing colonoscopy for different indications.

CANCER CAUSES & CONTROL (2023)

Article Gastroenterology & Hepatology

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles

Robert S. Bresalier, Carlo Senore, Graeme P. Young, James Allison, Robert Benamouzig, Sally Benton, Patrick M. M. Bossuyt, Luis Caro, Beatriz Carvalho, Han-Mo Chiu, Veerle M. H. Coupe, Willemijn de Klaver, Clasine Maria de Klerk, Evelien Dekker, Sunil Dolwani, Callum G. Fraser, William Grady, Lydia Guittet, Samir Gupta, Stephen P. Halloran, Ulrike Haug, Geir Hoff, Steven Itzkowitz, Tim Kortlever, Anastasios Koulaouzidis, Uri Ladabaum, Beatrice Lauby-Secretan, Marcis Leja, Bernard Levin, Theodore Robert Levin, Finlay Macrae, Gerrit A. Meijer, Joshua Melson, Colm O'Morain, Susan Parry, Linda Rabeneck, David F. Ransohoff, Roque Saenz, Hiroshi Saito, Silvia Sanduleanu-Dascalescu, Robert E. Schoen, Kevin Selby, Harminder Singh, Robert J. C. Steele, Joseph J. Y. Sung, Erin Leigh Symonds, Sidney J. Winawer

Summary: New non-invasive tests for colorectal cancer (CRC) are emerging, making it challenging to conduct trials with mortality reduction as the main goal. A formal consensus approach involving experts resulted in the revision of previously established principles and the emergence of twelve new principles. The effectiveness of a new test can be evaluated by comparing it with an established non-invasive test, with the faecal immunochemical test considered as the appropriate comparator. Flexible adjustment of the new test's positivity threshold is desirable to meet different screening goals and requirements. A four-phased approach is proposed for the evaluation of new tests, including small studies, prospective estimation of accuracy, evaluation in screening populations, and monitoring for missed lesions.
Article Gastroenterology & Hepatology

FIT for purpose: study protocol for a randomized controlled trial to personalize surveillance colonoscopy for individuals at elevated risk of colorectal cancer

Jean M. Winter, Kathryn J. Cornthwaite, Graeme P. Young, Carlene Wilson, Gang Chen, Richard Woodman, Michelle Coats, Robert Fraser, Charles Cock, Peter Bampton, Erin L. Symonds

Summary: The purpose of this study is to determine the safety, cost-effectiveness, and patient acceptance of extending colonoscopy surveillance intervals using the fecal immunochemical test (FIT) for individuals at elevated risk of colorectal cancer (CRC). Participants with a low FIT result will be randomized to either continue surveillance colonoscopy as scheduled or delay it by 1 or 2 years. The primary endpoint is the incidence of advanced neoplasia.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2023)

Letter Urology & Nephrology

Changes in symptom burden in the first 6 months after dialysis commencement: a prospective longitudinal observational cohort study

Richard Le Leu, Paul N. Bennett, Kathryn Dansie, Lisa Shanahan, Anna Chur-Hansen, Kathryn L. Collins, Anne L. J. Burke, Fiona Donnelly, Emily Duncanson, Anthony Meade, Stephen McDonald, Shilpanjali Jesudason

JOURNAL OF NEPHROLOGY (2023)

Article Nursing

Nephrology nurses' perspectives working with patients experiencing needle-related distress

Emily Duncanson, Richard K. Le Leu, Anna Chur-Hansen, Tahlia Masotti, Kathryn L. Collins, Anne L. J. Burke, Luke P. Macauley, Stephen Mcdonald, Shilpanjali Jesudason

Summary: This study aims to identify the key knowledge, skills and attitudes of nephrology nurses working with patients with needle-related distress. Two overarching themes were identified: Flexibility in Practice and Care, and Responsibility of Nephrology Nursing, which are relevant to all nephrology nurses. Additionally, the study found that nurses desire additional education regarding strategies to improve patient experience and nurse confidence and skill in cannulation.

JOURNAL OF RENAL CARE (2023)

暂无数据